Amgen 8-K
Leadership change
Former Yum! Brands CEO David Gibbs joins the board, bringing direct customer relationship experience to inform future product launches
Filed 2026-10-26 17:58 ET
- 5.02 Officer/director change
Summary
Amgen appointed David W. Gibbs to its board, effective 10/26/2026; he will serve on the Audit Committee and the Compensation and Management Development Committee. Gibbs was CEO of Yum! Brands from 2020 to September 2025 and also serves on the boards of Under Armour and PepsiCo. Amgen’s CEO said Gibbs’s experience building direct customer relationships will help inform future product launches and efforts to bring treatments to patients.
Key Figures
- Board composition: 13 directors, 12 independent.
- Director compensation through 12/31/2026: prorated annual cash retainer of $115,000 and committee member meeting retainers of $12,500.
- Equity compensation: a prorated 7/12 share of the $220,000 annual grant of fully vested restricted stock units, to be granted two business days after release of Amgen’s Q3 2026 earnings.
The summary is written by an AI model reading the filing.
Model 005 · prompt v111 · 2026-10-27 22:40:52Z